INTERNATIONAL BRAZ J UROL, vol.44, no.4, pp.734-739, 2018 (SCI-Expanded)
Purposes: The aim of this study was to determine the diagnostic significance of fibronectin type III domain containing protein 5 (FNDC5)/Irisin levels in the sera of patients with renal cell cancer.